Steve Gavel
Known title: Chief Commercial OfficerCIK: 0002090785
Steve Gavel's purchase track record
Steve Gavel has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 1/21/2026 | CABA | $50K | +35.5% | +17.5% | +9.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| CABA | ▲ Buy | Open Market | 22,170 | $50K | 1/21/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Cabaletta Bio Reports Inducement Grants Under Nasdaq Rule
Cabaletta Bio disclosed inducement grants made under Nasdaq Listing Rule 5635(c)(4). This is a standard regulatory filing that provides transparency on equity compensation issued to new employees. The stock is currently trading near its 52-week low, with technical indicators showing moderate selling pressure.
Cabaletta Bio Reports Inducement Grants Under Nasdaq Rule. Cabaletta Bio disclosed inducement grants made under Nasdaq Listing Rule 5635(c)(4). This is a standard regulatory filing that provides transparency on equity compensation issued to new employees. The stock is currently trading near its 52-week low, with technical indicators showing moderate selling pressure.